Predicting Tumor Outcome Following Cancer Vaccination by Monitoring Quantitative and Qualitative Cd8+ T Cell Parameters.
From: Department of Oncology and Surgical Sciences, University of Padova, Italy.
Journal of immunology (Baltimore, Md. : 1950)
- Publish Date: Feb 2006
- ISSN: 0022-1767
- Volume: 176
- Issue: 3
- Pages: 1999-2006
- Medium: Print
- Language: English
- Citation (JAMA): Rosato Antonio, Zoso Alessia, Dalla Santa Silvia, et al. Predicting Tumor Outcome Following Cancer Vaccination by Monitoring Quantitative and Qualitative Cd8+ T Cell Parameters.. J. Immunol. Feb 2006;176:1999-2006
Abstract
Identification of reliable surrogate predictors for evaluation of cancer vaccine efficacy is a critical issue in immunotherapy. We analyzed quantitative and qualitative CD8+ T cell parameters in a large pool of BALB/c mice that were DNA-vaccinated against P1A self tumor-specific Ag. After immunization, mice were splenectomized and kept alive for a subsequent tumor challenge to correlate results of immune monitoring assays with tumor regression or progression in each individual animal, and to assess the prognostic value of the assays. The parameters tested were 1) percentage of in vivo vaccine-induced tumor-specific CD8+ T cells; 2) results of ELISPOT tests from fresh splenocytes; 3) percentage of tumor-specific CD8+ T cells in culture after in vitro restimulation; 4) in vitro increase of tumor-specific CD8+ T cell population expressed as fold of expansion; and 5) antitumor lytic activity of restimulated cultures. Except for the ELISPOT assay, each parameter tested was shown by univariate statistical analysis to correlate with tumor regression. However, multivariate analysis revealed that only in vitro percentage of Ag-specific CD8+ T cells was an independent prognostic factor that predicted tumor outcome. These findings should be considered in the design of new immune monitoring systems used in cancer immunotherapy studies.
Mesh Headings (Keywords): Animals, Antigens, Neoplasm, CD8-Positive T-Lymphocytes, Cancer Vaccines, Cell Line, Tumor, Cell Proliferation, Cells, Cultured, Cytotoxicity Tests, Immunologic, Enzyme-Linked Immunosorbent Assay, Female, Lymphocyte Count, Mice, Mice, Inbred BALB C, Monitoring, Immunologic, Multivariate Analysis, Neoplasms, Experimental, Predictive Value of Tests, Prognosis, Vaccines, DNA
Check for Full Text / PubMed Unique Identifier (PMID): 16424232
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.